News
Turning Crisis into Strategy: Contracts, projects and disputes at a global chokepoint
Gregory P. Patti
Partner Corporate & Finance
-
Overview
-
Experience
-
Credentials
-
Insights and events
Greg Patti represents clients in a wide variety of mergers and acquisitions, securities and corporate governance matters. Greg represents foreign and domestic entities in complex business transactions and counsels clients on negotiated acquisitions, divestitures and private equity transactions.
Greg also regularly advises special purpose acquisition companies (SPACs) across the full range of transactions, including representing Pershing Square Tontine Holdings in its $4 billion IPO – the largest-ever IPO by a SPAC – for which he was named a “Dealmaker of the Year” by The American Lawyer.
In addition to his transactional practice, Greg counsels clients on a broad range of business-related matters including securities law, directors’ duties and responsibilities and disclosure matters. Greg has represented public and private acquirors, targets and portfolio companies. He has advised clients on numerous significant matters, particularly in the life sciences and telecom industries.
Greg has been recognized as a leading corporate lawyer by numerous industry publications, including having been named one of the “500 Leading Dealmakers in America” by Lawdragon in 2021, 2022 and 2024.
Greg received his J.D. from Harvard Law School, an M. Phil. in International Relations from the University of Cambridge, and a B.A., magna cum laude, from Yale University.
Representative experience
Thoma Bravo in its $10.4 billion acquisition of Anaplan, including with respect to Thoma Bravo's $2.25 per share reduction of the purchase price
Pershing Square Tontine Holdings, Ltd. in its $4 billion initial public offering – the largest-ever IPO by a special purpose acquisition company (SPAC), for which he was named a "Dealmaker of the Year" by The American Lawyer – and its agreement to acquire 10% of the outstanding Ordinary Shares of Universal Music Group B.V. ("UMG") from Vivendi S.E. for approximately $4 billion, representing an enterprise value of €35 billion (approximately $40 billion) for UMG
Pershing Square in the formation of a first-of-its-kind investment vehicle, Pershing Square SPARC Holdings, Ltd., a special purpose acquisition rights company
Thoma Bravo Advantage in its $1 billion initial public offering and $11.1 billion merger with ironSource
Mason Industrial Technology, Inc. in its $500 million initial public offering
Population Health Investment Co., Inc. in its $150 million initial public offering
Monocle Acquisition Corporation in its merger with AerSale Corp.
Bow Street LLC in its proxy contest with Mack-Cali Realty Corporation and successful effort to add eight new directors to the company's board
Corindus Vascular Robotics in its $1.1 billion acquisition by Siemens Healthineers AG
The Medicines Company in its agreement to sell its infectious disease business to Melinta Therapeutics, Inc. for $270 million and royalty payments on net sales of the pharmaceutical products sold to Melinta in the transaction
The Medicines Company in its agreement to divest three of its marketed cardiovascular products and related assets to Chiesi Farmaceutici S.p.A. for up to $792 million
The Medicines Company in connection with a Rule 144A offering of $402.5 million in aggregate principal amount of convertible senior notes due 2023
The Medicines Company in connection with its Exchange Act filings
Foresight Reserves, LP in the restructuring of its majority-owned subsidiary, Foresight Energy LP
Foresight Reserves LP in connection with securities matters relating to its positions in publicly traded companies
MedQuest, Inc. in the sale of 22 diagnostic imaging centers to Northside Hospital, Inc.
Salix Pharmaceuticals, Ltd. in its $15.6 billion acquisition by Valeant Pharmaceuticals International Inc.
Salix Pharmaceuticals, Ltd. in connection with securities filings relating to its 2015 restatement of financial results
Élan Corporation in its $8.6 billion sale to Perrigo Company plc
Élan Corporation in its successful defense of a $6.6 billion hostile tender offer by Royalty Pharma
Élan Corporation in connection with a Rule 144A offering of $850 million in aggregate principal amount of senior notes
Élan Corporation in connection with its Exchange Act filings
Élan Corporation in the spinoff of its drug discovery business into a new, independent publicly traded corporation, Prothena Corporation plc
United States Treasury Department in the restructuring of General Motors
J.P. Morgan Capital Partners, LLC in the $440 million sale of its MQ Associates, Inc. medical diagnostic imaging business to Novant Health
Sun Healthcare Group, Inc. in the $625 million acquisition of Harborside Healthcare Corporation from an affiliate of Investcorp
Verizon Communications in the sale of its Latin American directories business to an affiliate of Welsh, Carson, Anderson and Stowe
Sun Healthcare Group, Inc. in the sale of its home health care business to AccentCare, Inc.
Dynegy, Inc. in the $2.4 billion sale of its natural gas liquids business to an affiliate of Warburg Pincus
Verizon Communications in the $1.5 billion sale of its Canadian directories business to an affiliate of Bain Capital
Verizon Communications in the sale of the healthcare information technology business of its Verizon Information Technologies Inc. subsidiary to Infocrossing, Inc.
Sun Healthcare Group, Inc. in the sale of its pharmacies business to Omnicare Inc.
Verizon Communications in the sale if its BBNT Solutions subsidiary to an affiliate of General Catalyst Partners and Accel Partners
Qwest Communications International Inc. in the $7.05 billion sale of its QwestDex directories business to an affiliate of The Carlyle Group and Welsh, Carson, Anderson and Stowe
Galyan's Trading Company, Inc. in connection with its Exchange Act filings
Galyan's Trading Company Inc. in its initial public offering
Verizon Communications in the $800 million sale of its TSI Telecommunication subsidiary to an affiliate of GTCR Golder Rauner
GTE Corp. in the acquisition and sale of approximately $4.5 billion in cellular properties from and to Alltel Corporation
Telecom Italia Mobile in the acquisition of a Venezuelan cellular company
Credentials
Education
- J.D., Harvard Law School, 1992
- 1989
- B.A., Yale University, magna cum laude, 1988
Bar admissions and qualifications
- New York
News
Press releases
20 October 2025
Press releases
09 December 2024
Press releases
18 October 2024